Devices
That Defy
Failure
When high medical device failure rates from clogging, obstruction and biofouling are status quo, patients suffer and costs balloon.
Let’s reengineer the standard of care.
When high medical device failure rates from clogging, obstruction and biofouling are status quo, patients suffer and costs balloon.
Let’s reengineer the standard of care.
Get in touch and stay up to date with developments copy here copy here
The Power of Platform
Where will clog , obstruction and biofouling resistant devices transform the patient experience?
For Neurosurgery Patients
We are reinventing care for pediatric and adult hydrocephalous where:
- 98% of the leading hydrocephalus shunts fail within 10 years.
- 40% of the leading hydrocephalus shunts fail within 1 year.
Current products featuring Cerulean Surface technology:
- Hydrocephalus shunt
- Extraventricular drain
Cerulean technology “demonstrated increased survival time, improved clinical outcome scores, and significantly reduced total attached cells on the ventricular catheters compared with standard clinical control ventricular catheters.”
August 4, 2023
Journal of Neurosurgery
For Vascular Patients
We are dramatically improving vascular access for hemodialysis.
In a 90-day sheep study the leading hemodialysis catheter was 100% clogged with a 67% Fibrin Sheath.
A Cerulean Hemodialysis Catheter™ was 0% clogged with only a 3% Fibrin sheath.
Current products featuring Cerulean Surface technology:
- Hemodialysis catheter
- Vascular graft
The Power of a Physics-Based Approach
We partner with clinicians and researchers at leading universities
The Power of Partnership
We partner with clinicians and researchers at leading universities
Published in
The Power of People
100 years of combined medical device experience
